stella
Type 2 DiabetesNovember 2020Summary reviewed October 2026

Weekly Insulin Shot Works as Well as Daily for Type 2 Diabetes

People with type 2 diabetes who took a once-weekly insulin injection lowered their blood sugar just as much as those taking daily insulin — dropping their A1C by over 1 point in six months. Low blood sugar episodes were rare in both groups, and side effects were mild.

What the trial was testing

The trial enrolled 247 patients with type 2 diabetes. The study was sponsored by Novo Nordisk A/S and tracked outcomes across the full group of patients who matched the trial's eligibility profile.

It was initial testing (phase 2). Trials at this stage are designed to produce evidence regulators and physicians can act on — not just observations to follow up later.

What the results showed

Weekly insulin lowered A1C by 1.33 points — matching daily insulin's 1.15-point drop.

The New England journal of medicine · 2020 · NCT03751657

These findings — that weekly insulin lowered blood sugar as much as daily insulin — were published in the The New England journal of medicine and represent the headline result of the study.

Researchers tracked outcomes across 247 patients enrolled in the trial. The result was consistent enough across the group that the team felt confident reporting it.

What this means for patients

For patients with type 2 diabetes, this result changes the calculus on what to ask their care team about. Whether it changes day-to-day care depends on factors like disease subtype, prior treatments, and where the patient is in their care journey.

What you can do now

If you're starting insulin for type 2 diabetes, this weekly shot could be a simpler option than daily injections. This was a mid-stage study, so the weekly insulin isn't FDA-approved yet. Talk to your doctor about whether starting with daily insulin now makes sense, or if waiting for this weekly option might work for you.

Eligibility for the treatments mentioned above depends on specific test results and clinical history. Bring this summary, the trial name, and your most recent labs or pathology report to your next visit.